Fertility Services Market
Fertility Services Market
The market for Fertility Services was estimated at $51.16 billion in 2024; it is anticipated to increase to $79.0 billion by 2030, with projections indicating growth to around $113 billion by 2035.
Global Fertility Services Market Outlook
Revenue, 2024 (US$B)
$51.2B
Forecast, 2034 (US$B)
$105B
CAGR, 2024 - 2034
7.5%
Market Key Insights
- The Fertility Services market is projected to grow from $51.2 billion in 2024 to $105 billion in 2034. This represents a CAGR of 7.5%, reflecting rising demand across Assisted Reproductive Technology (ART) Services, Egg and Sperm Cryopreservation Services and Fertility Diagnostics Services.
- Virtus Health, Monash IVF Group, Care Fertility Group are among the leading players in this market, shaping its competitive landscape.
- U.S. and Canada are the top markets within the Fertility Services market and are expected to observe the growth CAGR of 4.9% to 7.2% between 2024 and 2030.
- Emerging markets including Brazil, South Africa and Malaysia are expected to observe highest growth with CAGR ranging between 8.6% to 10.3%.
- Transition like Upsurge in Assisted Reproductive Technology adoption is expected to add $7.6 billion to the Fertility Services market growth by 2030
- The Fertility Services market is set to add $54.3 billion between 2024 and 2034, with manufacturer targeting Intracytoplasmic Sperm Injection & Intrauterine Insemination Treatment Type projected to gain a larger market share.
- With Rising trend of delayed pregnancies, and Technological advancements in fertility procedures, Fertility Services market to expand 106% between 2024 and 2034.
Opportunities in the Fertility Services
Advancements in technology are pushing the limits of fertility treatment options forward. The development of apps for fertility tracking, mobile devices and home based diagnostic tools indicate a direction, for customized and convenient fertility care services.
Growth Opportunities in North America and Asia Pacific
North America Outlook
Asia Pacific Outlook
Market Dynamics and Supply Chain
Driver: Rising trend of Delayed Pregnancies, and Increasing Prevalence of Infertility
Restraint: High Cost of Treatment
Opportunity: Male Infertility An Underserved Market and IVF Tourism on the Rise
Challenge: Social Stigma and Cultural Barriers
Supply Chain Landscape
Diagnostic Services and Initial Assessment
Labcorp Inc.
OPKO Health Inc
Fertility Drugs Production
Merck & Co. Inc.
Ferring Pharmaceuticals
Assisted Reproductive Technologies (ART) Equipment Manufacturing
The Cooper Companies Inc.
Cook Medical LLC
Fertility Clinics and Hospitals
Virtus Health
The US Fertility Network
Diagnostic Services and Initial Assessment
Labcorp Inc.
OPKO Health Inc
Fertility Drugs Production
Merck & Co. Inc.
Ferring Pharmaceuticals
Assisted Reproductive Technologies (ART) Equipment Manufacturing
The Cooper Companies Inc.
Cook Medical LLC
Fertility Clinics and Hospitals
Virtus Health
The US Fertility Network